We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Partnership to Develop Cardiac PET

By MedImaging staff writers
Posted on 26 Jan 2006
Imagin Molecular Corp. (IMGM, Oakbrook, IL, USA) has entered into an agreement with PET Management Services (PMS, Niagara, NY, USA) to pursue molecular imaging partnerships.

PET Management Services is a developer of molecular imaging systems that bring to IMGM, formerly known as Cipher Multimedia, Inc., the necessary bioinformatics research and imaging center management that validates the usefulness of positron emission tomography (PET) as a primary coronary diagnostic tool.

PMS enables Imagin Nuclear Partners (INP), Imagin Molecular's subsidiary, to provide dedicated evidence-based medical systems for cardiac disease diagnostics and treatments driven by bioinformatics. PMS has data that demonstrate cost-savings to insurance companies when cardiac PET is performed on selected patients as a first-line modality rather than single photon computed tomography (SPECT) scans.

PMS will partner with INP and will operate joint ventures with PET imaging centers. INP is a full-service joint venture molecular imaging partner that will own, operate, and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment.

Joe Oliverio, president of PET Management Services stated, "We have one of the most robust cardiac PET patient databases and are preparing to publish manuscripts that will revolutionize the way coronary disease detection and management is performed for decades to come.”




Related Links:
Imagin Molecular
Mobile X-Ray System
K4W
MRI System
nanoScan MRI 3T/7T
Mammo DR Retrofit Solution
DR Retrofit Mammography
Pocket Fetal Doppler
CONTEC10C/CL

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.